Cumulus Oncology
Pharmaceutical Manufacturing
United Kingdom
19 employees
- Employees
- 19
- Contacts
- 4
- Emails
- 4
- Phones
- 2
Cumulus Oncology Overview
- Headquarters
- United Kingdom
- Website
- cumulusoncology.com
- Industry
- Pharmaceutical Manufacturing
- Employees
- 19
- Founded
- 2017
- Funding
- 11.5M
- Company Email
- Available in AeroLeads
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation Manufacturing
About Cumulus Oncology
Cumulus Oncology is developing anti-cancer therapies for clinical settings in areas of high unmet need, with the aim of developing improved outcomes for cancer patients. Cumulus has the backing of a successful entrepreneur in the oncology field, and is led by a team of senior professionals, each bringing a wealth of experience across a range of areas including licensing and business development, oncology drug discovery, pre-clinical and clinical development, who have delivered programs leading to the approval and commercial success of new treatments in oncology. We are keen to hear from organisations who are looking to partner late discovery and clinical stage oncology assets.
Cumulus Oncology Contact Details
- People in AeroLeads
- 4
- With contact data
- 4
- Email contacts
- 4
- 100.0% coverage
- Phone contacts
- 2
- 50.0% coverage
Cumulus Oncology Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Scott Doak | Edinburgh, Scotland, United Kingdom |
Email
|
|
| Brian Gallagher, Jr. | Biotech Investor, Entrepreneur, Board | Boston, Massachusetts, United States |
Email
Phone
|
| Glen Clack | Honorary Professor of Translational | Macclesfield, England, United Kingdom |
Email
|
| John Haurum | Copenhagen, Capital Region of Denmark, Denmark |
Email
Phone
|
Employees by Management Level
Individual contributor
3 profiles
Senior / Lead
2 profiles
Department Contact Coverage
| Department | Contacts | Phone | |
|---|---|---|---|
| Operations | 2 | 2 | 2 |
Compare Similar Companies to Cumulus Oncology
Quotient Therapeutics
Biotechnology Research
Infinitopes
Biotechnology Research
Bioptimus
Biotechnology Research
leadXpro AG
Biotechnology Research
Commit Biologics
Biotechnology
ARTICA Therapeutics
Biotechnology Research
Draupnir Bio
Biotechnology Research
Adcytherix
Biotechnology Research
GIO Therapeutics
Biotechnology Research
Nodus Oncology
Biotechnology Research